(Date:10/6/2008)...ctober 10th, military personnel and their family m...person self-assessments, BOSTON, Oct. 6 /PRNewswi...nges to Service members and their families that ar...are not. In some instances matters get,worse and o...At such times,it is wise to check things out to se...
(Date:10/6/2008)...y led by researchers at the University of Californ... of oral Vitamin D supplements bolsters production...in, and may help prevent skin infections that are ...mon form of eczema. , The study led by Richard ...f of the Division of Dermatology at the UCSD Schoo...
(Date:10/6/2008)...TLE, Oct. 6 /PRNewswire/ -- A special supplement o...tails guidelines for low- and,middle-income countr...and,treat the most common disease among women worl...th and Cancer Control -,Implementation" developed ...ines a tiered system of resource allocation -- bas...
(Date:10/6/2008)...MBUS, Ohio, Oct. 6 /PRNewswire/ -- Ohio,s academic... the state,s economy in 2007, an,increase of appro... major,job generator, employing one in 12 Ohioans,...hio Council of Medical Deans., Quantifying academ...m,tax revenue to job creation, the report undersco...
Breaking Medicine News(10 mins):Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 3Health News:Oral vitamin D may help prevent some skin infections 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 3Health News:Academic Medicine Means Business for Ohio: $37.2 Billion Economic Impact for the State 2(Date:10/6/2008)...l Associations Collaborate to Improve Patient Safe... The American College of,Cardiology in collaborati...nd the American Heart Association today released c...for reducing the risk of ulcers and,gastrointestin...,anti-inflammatory drugs (NSAIDs) along with antip...
(Date:10/6/2008)... Calif. and SEATTLE, Oct. 6 /- Comple...on human genome sequencing,company, and the Instit...r,partnership to conduct populationwide human geno...e Genomics will use its proprietary,DNA sequencing...provided by,ISB. Then, once proof-of-concept has b...
(Date:10/6/2008)...6 /- Dendreon Corporation (...onday, October 6, 2008 at 9:00 AM,ET (6:00 AM PT) ...ts IMPACT,(IMmunotherapy for Prostate AdenoCarcino... of PROVENGE(R) (sipuleucel-T), the Company,s inve...treatment of advanced prostate,cancer., Those ...
(Date:10/3/2008)...ober 3 /- Amsterdam Molecul...ield of human gene therapy,announced today that i...Marketing Authorization Application (MAA) for Glyb... seriously debilitating and potentially lethal,dis... clinical studies (22,patients in total) demonstra...
Breaking Medicine Technology:Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 3Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre Symptomatic Detection of Disease 10231 1Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre Symptomatic Detection of Disease 10231 2Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre Symptomatic Detection of Disease 10231 3Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 10227 1Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 10227 2Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 10227 3Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 10227 4Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing 2763 1Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing 2763 2Arbor Surgical Technologies Announces Series C Financing and Licensing Agreement with Medtronic 2759 1Arbor Surgical Technologies Announces Series C Financing and Licensing Agreement with Medtronic 2759 2...ON, N.J.--(BUSINESS WIRE)--Apr 26, 2007 - Columbia... that preliminary,results from the ongoing data an...bo-controlled, double-blind Phase III clinical,tri...revention of,preterm birth in women with a previou...s revealed a possible effect of PROCHIEVE 8%,in de...
... Australia, April 26, 2007 /PRNewswire-FirstCall/ ...mited today,announced preliminary results from its...th metastatic colorectal cancer, where,Alchemia,s ...s,considered to be a cornerstone drug for the trea...eing made at a preliminary stage of,the analysis i...
Other Medicine Technology:Columbia Laboratories Reports Preliminary Findings from the Ongoing,Data Analysis of the Phase III Clinical Study of PROCHIEVE 8%,(progesterone gel) to Prevent Preterm Birth 2Columbia Laboratories Reports Preliminary Findings from the Ongoing,Data Analysis of the Phase III Clinical Study of PROCHIEVE 8%,(progesterone gel) to Prevent Preterm Birth 3Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 2Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 3Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 4Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 5Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 6Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 7This new dedicated VICTOR2 model is for fluorescence and luminescence measurements.
VICTOR2 V measures prompt fluorescence, fluorescence polarization, luminescence, time-resolved fluorescence and absorbance. This model includes high density TRF (for 1536-well plates), temperature
This a new dedicated VICTOR2 model for fluorescence and luminescence detection with stacker and robotic loading.
The basic modular version of the VICTOR2 multilabel counter for fluorescence, luminescence and absorption measurements, with the stacker and the robotic loading configuration.
Medicine Products: